3-HO-PCE Powder
€35.00
Product Specifications (EU Lab-Grade)
| Category | Details |
|---|---|
| Chemical Name | 3-Hydroxyeticyclidine (3-HO-PCE) |
| Form | Fine Research Powder |
| Purity | ≥ 98% (confirmed by laboratory testing) |
| Chemical Class | Dissociative Arylcyclohexylamine |
| Use | For scientific & analytical research only |
| Packaging | Vacuum-sealed, moisture-protected, tamper-evident |
| Compliance | Not for human consumption |
Our products are packaged with maximum discretion and shipped via reliable logistics for EU researchers.
Description
Buy 3-HO-PCE Powder Online – Premium EU Research-Grade Dissociative
Looking to order high-purity 3-HO-PCE (3-Hydroxyeticyclidine) powder for advanced laboratory analysis? Our EU-based research supply platform provides premium dissociative arylcyclohexylamine compounds trusted by scientific institutions and neurochemical researchers across Europe.
3-HO-PCE is known for its distinct pharmacological profile within the arylcyclohexylamine class, making it a valuable compound for receptor-binding research, neuropharmacology, and chemical analysis.
We ensure each batch is lab-verified for purity, consistency, and stability—meeting strict European research standards.
Why Buy 3-HO-PCE Powder From Us (EU Supplier)?
-
Premium, lab-tested purity for dependable research results
-
EU-based distribution for fast, smooth delivery across Europe
-
Strict quality control & documentation
-
Secure and discreet packaging ensuring safety and privacy
-
Trusted supplier for European research facilities
-
Responsive customer support for researchers and labs
Your scientific research deserves uncompromised quality.
Our 3-HO-PCE powder meets the standards required by professional laboratories across the EU.
🚚 EU-Friendly & International Shipping
We provide discreet, reliable delivery to research institutions in:
-
Netherlands (NL)
-
Germany (DE)
-
France (FR)
-
Belgium (BE)
-
Spain (ES)
-
Italy (IT)
-
Switzerland (CH)
-
Poland (PL)
-
Austria (AT)
-
Portugal (PT)
-
Greece (GR)
And many more EU/EEA regions.
Global research destinations such as the UK, Canada, Australia, and Singapore also supported.


